Navigation Links
New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
Date:6/7/2008

Results Presented at the ADA's Annual Scientific Sessions

SAN FRANCISCO, June 7 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the results of the dose-finding study for its new injectable diabetes compound AVE0010, a GLP-1 agonist, were presented at the American Diabetes Association's (ADA) 68th Annual Scientific Sessions meeting in San Francisco, California.

The study found that AVE0010 was well tolerated and significantly improved glycemic control versus placebo in type 2 diabetes patients inadequately controlled with metformin alone. The once daily regimen demonstrated a clear dose response with a similar HbA1c reduction to twice daily regimen. AVE0010 was also found to be associated with weight loss and reductions in postprandial glucose.

"The results of the once daily AVE0010 regimen are very promising and this new GLP-1 agonist has a potential to become an important addition to the treatment armamentarium for type 2 diabetes," said Robert Ratner, from the MedStar Research Institute Washington DC, Principal Investigator of the dose-finding study.

About the Study

The dose-finding study involved 542 type 2 diabetes patients inadequately controlled on metformin monotherapy (1.6-1.9 g/day). In this double-blind study, patients were randomized to receive for 13 weeks, either AVE0010 subcutaneously at the doses of 5, 10, 20 and 30 micron(g) once daily or twice daily, or placebo. The primary endpoint was change in HbA1c from baseline. Secondary endpoints included weight change and 2-hour post-prandial plasma glucose (PPG).

Baseline characteristics were similar among groups in terms of mean age (56 +/-9 years), diabetes duration (6.6 +/-5 years), HbA1c (7.5 +/-0.6%) and Body Mass Index (31.9 +/-4 kg/m2). Despite mildly elevated baseline HbA1c, the results of the study demonstrated a highly statistically significant dose response with a net decrease in mean HbA1c from baseline subtracted from placebo f
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
2. DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes
3. Study Shows Lantus(R) Helped People Living with Type 2 Diabetes Reach the ADAs Recommended Target for Blood Sugar Control
4. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
5. International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
6. Naturally Occurring Compounds in Cocoa Tied to Blood Flow Improvements for Adults With Type 2 Diabetes
7. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
8. Continued Funding to Help Advance Exciting Moment in Diabetes Research
9. CureDMs Diabetes Therapy Achieves Major Development Milestone
10. Drug Combo Could Lower Diabetes Complications and Costs
11. Discovery Leads to Earlier Diagnosis of Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015 According to a ... Active Pharmaceutical Ingredients (API) Market - Global Industry Analysis, ... " the global active pharmaceutical ingredients market was valued ... to reach USD 185.9 billion by 2020, expanding at ... 2014 to 2020. Full Research Report on ...
(Date:7/29/2015)... , July 24, 2015 Research ... addition of the "Global Wound Care Markets ... United States, Japan, Canada, China, India, Brazil, Australia, ... The report provides a competitive market ... terms of both product offerings and product maturity. ...
(Date:7/29/2015)... YORK , July 29, 2015 /PRNewswire/ ... a new research report "Global Industry Insight: ... to 2020" with market overview, trends, DRO analysis, ... analysis, recent developments, competitive scenario and top ... http://photos.prnewswire.com/prnh/20150727/756778 ) Microfluidic devices  ...
Breaking Medicine Technology:Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5Global Wound Care Markets 2015 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 2Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 3Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 4Global Microfluidic Devices Market (Size of $1,886 Million in 2014) to Witness a CAGR of 23% During 2015 - 2020 5
... The Board of the European Fine Chemicals Group (EFCG) ... the proposal of the US Food and Drug Administration (FDA) ... of EFCG and US industry representatives, to deliver into US ... GDUFA requires the FDA to commit to significantly improve ...
... PRA, a leading Clinical Research Organization, announces that two ... will present at the European World Drug Safety Congress ... will also host an exhibit at booth #2, where ... approach to pharmacovigilance. Dr. Sabine Richter, PRA,s ...
Cached Medicine Technology:European Fine Chemicals Group Ratifies FDA's Proposed Generic Drug User Fees Act (GDUFA) 2PRA Experts to Speak at Drug Safety Conference Breakout Session on Risk Management Strategies 2
(Date:7/29/2015)... ... July 29, 2015 , ... ... anticipating testing regulations imposed by the FDA for nicotine laced liquid products. Their ... electronic cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as ...
(Date:7/29/2015)... Waukesha, WI (PRWEB) , ... July 29, 2015 ... ... area, Scott Campbell Agency has once again teamed up with Stillwaters Cancer Support ... patients and their families. Stillwaters provides individual and family counseling, support groups, workshops ...
(Date:7/29/2015)... ... ... For the second year in a row, the management and staff of Vast ... companies in Jacksonville. This annual list is compiled by the Jacksonville Business Journal, a ... Bridges staffers were on hand to receive the award naming the company the 16th ...
(Date:7/29/2015)... Los Angeles, CA (PRWEB) , ... July 29, 2015 , ... We are privileged to ... at Keck Medicine of USC as the ninth best ophthalmology hospital in the nation for ... the top 10 American hospitals for ophthalmology. , “It is an honor to be ...
(Date:7/29/2015)... ... 29, 2015 , ... July is National UV Awareness Month, and in honor of this month, ... how to protect skin from the sun, as well as how to best treat existing ... of the most common skin conditions in America. Many people do not protect their skin ...
Breaking Medicine News(10 mins):Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3Health News:Vast Bridges Continues Its Swift Growth 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 2Health News:July is UV Awareness Month: Learn Top Tips from a Prominent Dermatologist this National UV Awareness Month 3
... sex life of the African naked mole-rat is helping scientists ... ,Mole-rats are blind, hairless, and live in large ... ,In a new study, scientists, by examining these ... fertility in both men and women, a subject which is ...
... Venezuelan President Hugo Chavez has threatened to nationalise private hospitals ... ,Chavez made a nationally televised speech, saying that the ... the public health service if they failed to abide by ... clinics as a symptom of "the evil of capitalism", which ...
... to determine the knot-like structure of enzymes, but theyve been ... of function what the enzyme actually does in the ... many of the most successful drugs work by blocking enzyme ... that a solution to the puzzle is finally in sight. ...
... septic tanks trapped by methane gas is commonplace in developing ... up in the West too. Fiver persons fell victims to ... dairy farm in Shenandoah Valley, Virginia, US Monday evening. ... the pit to unclog a pipe was the first to ...
... exploring choices made by childless couples facing in-vitro fertility ... clues about mood swings that heavily influenced a life-altering ... entails retrieving eggs from the woman's ovary and fertilising ... creating embryos that can then be implanted into the ...
... figures presented at the European Society of Human Reproduction ... protection law has had the unintended consequence of increasing ... , ,The German embryo protection law, passed in 1991, ... created per cycle of IVF and all three, regardless ...
Cached Medicine News:Health News:Strange Sex Life of Mole-rats may Provide Clues About Human Infertility 2Health News:Translating Structure into Function 2Health News:Five Killed by Methane Gas on Virginia Farm 2Health News:Five Killed by Methane Gas on Virginia Farm 3Health News:Test-tube Babies: Mood Swings are Key to Fertility Choice 2Health News:Embryo Protection Law in Germany 2Health News:Embryo Protection Law in Germany 3Health News:Embryo Protection Law in Germany 4
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Medicine Products: